iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://pubmed.ncbi.nlm.nih.gov/15668979/
Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 Feb;57(2):298-302.
doi: 10.1002/ana.20374.

Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study

Nikunj K Patel  1 , Martin Bunnage, Puneet Plaha, Clive N Svendsen, Peter Heywood, Steven S Gill
Affiliations
Clinical Trial

Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study

Nikunj K Patel et al. Ann Neurol. 2005 Feb.

Abstract

We have shown previously that intraparenchymal infusion of glial cell line-derived neurotrophic factor (GDNF) continuously into the posterior putamen in five Parkinson's disease patients is safe and may represent a new treatment option. Here, we report a continuation of this phase I study. After 2 years of continual GDNF infusion, there were no serious clinical side effects and no significant detrimental effects on cognition. Patients showed a 57% and 63% improvement in their off-medication motor and activities of daily living subscores of the Unified Parkinson's Disease Rating Scale, respectively, and health-related quality-of-life measures (Parkinson's Disease Questionnaire-39 and Short Form-36) showed general improvement over time.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms

Substances

LinkOut - more resources